Back to Search
Start Over
Management of radiation oncology patients with a pacemaker or ICD: A new comprehensive practical guideline in The Netherlands
- Source :
- Radiation Oncology, Vol 7, Iss 1, p 198 (2012), Radiation Oncology (London, England)
- Publication Year :
- 2012
- Publisher :
- BMC, 2012.
-
Abstract
- Current clinical guidelines for the management of radiotherapy patients having either a pacemaker or implantable cardioverter defibrillator (both CIEDs: Cardiac Implantable Electronic Devices) do not cover modern radiotherapy techniques and do not take the patient’s perspective into account. Available data on the frequency and cause of CIED failure during radiation therapy are limited and do not converge. The Dutch Society of Radiotherapy and Oncology (NVRO) initiated a multidisciplinary task group consisting of clinical physicists, cardiologists, radiation oncologists, pacemaker and ICD technologists to develop evidence based consensus guidelines for the management of CIED patients. CIED patients receiving radiotherapy should be categorised based on the chance of device failure and the clinical consequences in case of failure. Although there is no clear cut-off point nor a clear linear relationship, in general, chances of device failure increase with increasing doses. Clinical consequences of device failures like loss of pacing, carry the most risks in pacing dependent patients. Cumulative dose and pacing dependency have been combined to categorise patients into low, medium and high risk groups. Patients receiving a dose of less than 2 Gy to their CIED are categorised as low risk, unless pacing dependent since then they are medium risk. Between 2 and 10 Gy, all patients are categorised as medium risk, while above 10 Gy every patient is categorised as high risk. Measures to secure patient safety are described for each category. This guideline for the management of CIED patients receiving radiotherapy takes into account modern radiotherapy techniques, CIED technology, the patients’ perspective and the practical aspects necessary for the safe management of these patients. The guideline is implemented in The Netherlands in 2012 and is expected to find clinical acceptance outside The Netherlands as well.
- Subjects :
- Male
Pacemaker, Artificial
DEVICES
medicine.medical_treatment
Review
Guideline
THERAPY
Neoplasms
Tachycardia
Implantable cardioverter defibrillator
Disease management (health)
Risk management
Netherlands
COMPLICATIONS
Evidence-Based Medicine
POSTTRAUMATIC STRESS
Disease Management
Radiotherapy Dosage
Focus Groups
Implantable cardioverter-defibrillator
lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Defibrillators, Implantable
Electrodes, Implanted
Pacemaker
Oncology
Radiology Nuclear Medicine and imaging
Equipment Failure
Female
Patient Safety
Electromagnetic Phenomena
lcsh:Medical physics. Medical radiology. Nuclear medicine
medicine.medical_specialty
Evidence-based practice
LATEST GENERATION
IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR
lcsh:R895-920
Cardiology
lcsh:RC254-282
CARDIAC-PACEMAKERS
Patient safety
medicine
Humans
Radiology, Nuclear Medicine and imaging
Intensive care medicine
Patient Care Team
ELECTROMAGNETIC-INTERFERENCE
Radiotherapy
business.industry
Evidence-based medicine
IRRADIATION
Radiation therapy
Semiconductors
Radiation Oncology
Dose Fractionation, Radiation
business
CIED
Subjects
Details
- Language :
- English
- Volume :
- 7
- Issue :
- 1
- Database :
- OpenAIRE
- Journal :
- Radiation Oncology
- Accession number :
- edsair.doi.dedup.....49acc614432a54718a94406d45870b6a